OVERLEGE ANDVORDS TUBERKULOSELEGAT STI

STIActive

Org 977132932Activities of other membership organisations n.e.c. · NACE 9499Est. 19810 employeeswww.unifor.no

Overview Financials People & ownership Related companies

OVERLEGE ANDVORDS TUBERKULOSELEGAT STI is a Norwegian STI, operating in the Aktiviteter i fond/legat som støtter veldedige og allmennyttige formål sector. Incorporated in 1981, the company has 0 employees and reported revenue of NOK 708K in its latest annual filing.

Revenue 2024

NOK 708K

+10% vs 2023

EBITDA margin

97.6%

+10% vs 2023

Equity ratio

100.0%

Financial strength

Net profit 2024

NOK 690K

+10% vs 2023

EBITDA — year on year

NOK millions

Key figures

Annual report 2024

Revenue	NOK 708K	+10%
EBITDA	NOK 690K	+10%
Net profit	NOK 690K	+10%
Total assets	NOK 4,7M	+17%
Equity	NOK 4,7M	+17%
Employees	0	—

Contact

Address

Website

www.unifor.no

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of OVERLEGE ANDVORDS TUBERKULOSELEGAT STI?

OVERLEGE ANDVORDS TUBERKULOSELEGAT STI is registered with Brønnøysundsregistrene under Org 977132932.

What is the revenue of OVERLEGE ANDVORDS TUBERKULOSELEGAT STI?

OVERLEGE ANDVORDS TUBERKULOSELEGAT STI reported revenue of NOK 708K in 2024.

Who is the CEO of OVERLEGE ANDVORDS TUBERKULOSELEGAT STI?

Hans Jørgen Stang is Contact Person of OVERLEGE ANDVORDS TUBERKULOSELEGAT STI, in role since 2008.

Who is the chairman of OVERLEGE ANDVORDS TUBERKULOSELEGAT STI?

Bjarne Borgersen chairs the board of OVERLEGE ANDVORDS TUBERKULOSELEGAT STI, in role since 2020.

OVERLEGE ANDVORDS TUBERKULOSELEGAT STI

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on OVERLEGE ANDVORDS TUBERKULOSELEGAT STI

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on OVERLEGE ANDVORDS TUBERKULOSELEGAT STI